Genes help with Huntington's

UK researchers slowed the progression of the fatal neural condition Huntington’s disease for the first time with a groundbreaking new gene therapy.

- 

Some patients who took part in early-stage clinical trials at University College London (UCL), saw the speed at which their condition developed reduced by 75% after three years, according to uniQure, a gene therapy company based in the Netherlands and the United States.

The study tested a new gene therapy, AMT-130, which is delivered through an injection directly into the brain.